Contact Information

Call us at: (614) 355-6778

Email Afrooz Rashnonejad, MSc, PhD

Center for Gene Therapy700 Children’s DriveColumbus, OH 43205 (map)

Learn more about Afrooz Rashnonejad

Research

Lab(s)

Center for Gene Therapy

The Rashnonejad Lab’s research focuses on the development of Adeno-Associated Virus (AAV)-based gene therapies for neurodegenerative and neuromuscular disorders using cutting-edge technologies such as RNAi and CRISPR. Rashnonejad lab is improving PNS targeting by engineering AAV vectors toward developing gene therapies for peripheral neuropathies including Charcot-Marie-Tooth disease (CMT1B and Dejerine–Sottas syndrome (DSS)). Rashnonejad lab is also interested to develop in-utero gene therapies for severe neuromuscular disorders.

Biography

Afrooz Rashnonejad, MSc, PhD, is an assistant professor in the Department of Pediatrics at the Ohio State University College of Medicine and principal investigator in the Center for Gene Therapy at the Abigail Wexner Research Institute at Nationwide Children’s Hospital. Dr. Rashnonejad is the chair of the American Society of Gene and Cell therapy (ASGCT)’s New Investigator Committee and she was twice awarded the “Excellence in Research Award” at the ASGCT annual meetings. Dr. Rashnonejad earned her PhD in Biotechnology from Ege University, Turkey, in 2017, after completing two Master’s of Science degrees in Microbiology, and Stem Cell. During her PhD, she developed an in-utero (AKA prenatal or fetal) gene therapy for Spinal Muscular Atrophy (SMA). During this period, she also worked in Dr. Guangping Gao (her PhD co-advisor)’s lab in the Center for Gene Therapy at the University of Massachusetts Medical School as a visiting scientist to master large-scale recombinant AAV production. She then completed postdoctoral training in the lab of Scott Harper, PhD, at the Center for Gene Therapy at Nationwide Children’s Hospital. During her postdoc, Dr. Rashnonejad developed RNA targeting AAV.CRISPR-Cas13 and U7-snRNA mediated exon skipping to treat autosomal dominant inherited Facioscapulohumeral Muscular Dystrophy (FSHD).

Academic and Clinical Areas

Center for Gene Therapy

Principal Investigator

Primary Department

Center for Gene Therapy

Awards, Honors & Organizations

Excellence in Research Award, 23rd ASGCT Annual Meeting, USA, 2020 President’s Prize, 24th World Muscle Society (WMS), Copenhagen, Denmark, 2019 Excellence in Research Award, 22nd ASGCT Annual Meeting, Washington DC, USA, 2019 Best Project Award, National Health Science Project Competition, UPROJECT, Turkey, 2016 PhD Fellowship Award, the Scientific and Technological Research Council of Turkey, (TUBITAK/BIDEB-2215), 2012-2015 Chair, American Society for Gene and Cell Therapy (ASGCT) New Investigator Committee, USA, 2021 - Present Member, Peripheral Nerve Society (PNS), 2021 - Present Chair, Research Institute Trainee Association (RITA), Nationwide Children’s Hospital, 2021 - 2022 Member, International Fetal Transplantation and Immunology Society (IFETIS), USA, 2020 - Present Member, World Muscle Society (WMS), 2019 - Present Associate Member, American Society for Gene and Cell Therapy (ASGCT), USA, 2017 - Present Member, American Society for Biochemistry and Molecular Biology, USA, 2017 - Present Member, National Postdoctoral Association, USA, 2017 - 2022

Education

Postdoctoral Training

Nationwide Children’s Hospital

Date Completed: 03/31/2022

Graduate School

Ege University

Date Completed: 04/30/2017

Professional Experience

2022 - Present Nationwide Children’s Hospital, Principal Investigator2022 - Present The Ohio State University, Assistant Professor2017 - 2022 Nationwide Children’s Hospital, Postdoctoral Fellow

Contact Information

Center for Gene Therapy

Call us at: (614) 355-6778

Email Afrooz Rashnonejad

                    700 Children's DriveColumbus, OH 43205 (map)

Connect with Afrooz Rashnonejad

Connect on LinkedIn

Contact Information

Call us at: (614) 355-6778

Email Afrooz Rashnonejad, MSc, PhD

Center for Gene Therapy700 Children’s DriveColumbus, OH 43205 (map)

Learn more about Afrooz Rashnonejad

Research

Lab(s)

Center for Gene Therapy

The Rashnonejad Lab’s research focuses on the development of Adeno-Associated Virus (AAV)-based gene therapies for neurodegenerative and neuromuscular disorders using cutting-edge technologies such as RNAi and CRISPR. Rashnonejad lab is improving PNS targeting by engineering AAV vectors toward developing gene therapies for peripheral neuropathies including Charcot-Marie-Tooth disease (CMT1B and Dejerine–Sottas syndrome (DSS)). Rashnonejad lab is also interested to develop in-utero gene therapies for severe neuromuscular disorders.

Biography

Afrooz Rashnonejad, MSc, PhD, is an assistant professor in the Department of Pediatrics at the Ohio State University College of Medicine and principal investigator in the Center for Gene Therapy at the Abigail Wexner Research Institute at Nationwide Children’s Hospital. Dr. Rashnonejad is the chair of the American Society of Gene and Cell therapy (ASGCT)’s New Investigator Committee and she was twice awarded the “Excellence in Research Award” at the ASGCT annual meetings. Dr. Rashnonejad earned her PhD in Biotechnology from Ege University, Turkey, in 2017, after completing two Master’s of Science degrees in Microbiology, and Stem Cell. During her PhD, she developed an in-utero (AKA prenatal or fetal) gene therapy for Spinal Muscular Atrophy (SMA). During this period, she also worked in Dr. Guangping Gao (her PhD co-advisor)’s lab in the Center for Gene Therapy at the University of Massachusetts Medical School as a visiting scientist to master large-scale recombinant AAV production. She then completed postdoctoral training in the lab of Scott Harper, PhD, at the Center for Gene Therapy at Nationwide Children’s Hospital. During her postdoc, Dr. Rashnonejad developed RNA targeting AAV.CRISPR-Cas13 and U7-snRNA mediated exon skipping to treat autosomal dominant inherited Facioscapulohumeral Muscular Dystrophy (FSHD).

Academic and Clinical Areas

Center for Gene Therapy

Principal Investigator

Primary Department

Center for Gene Therapy

Awards, Honors & Organizations

Excellence in Research Award, 23rd ASGCT Annual Meeting, USA, 2020 President’s Prize, 24th World Muscle Society (WMS), Copenhagen, Denmark, 2019 Excellence in Research Award, 22nd ASGCT Annual Meeting, Washington DC, USA, 2019 Best Project Award, National Health Science Project Competition, UPROJECT, Turkey, 2016 PhD Fellowship Award, the Scientific and Technological Research Council of Turkey, (TUBITAK/BIDEB-2215), 2012-2015 Chair, American Society for Gene and Cell Therapy (ASGCT) New Investigator Committee, USA, 2021 - Present Member, Peripheral Nerve Society (PNS), 2021 - Present Chair, Research Institute Trainee Association (RITA), Nationwide Children’s Hospital, 2021 - 2022 Member, International Fetal Transplantation and Immunology Society (IFETIS), USA, 2020 - Present Member, World Muscle Society (WMS), 2019 - Present Associate Member, American Society for Gene and Cell Therapy (ASGCT), USA, 2017 - Present Member, American Society for Biochemistry and Molecular Biology, USA, 2017 - Present Member, National Postdoctoral Association, USA, 2017 - 2022

Education

Postdoctoral Training

Nationwide Children’s Hospital

Date Completed: 03/31/2022

Graduate School

Ege University

Date Completed: 04/30/2017

Professional Experience

2022 - Present Nationwide Children’s Hospital, Principal Investigator2022 - Present The Ohio State University, Assistant Professor2017 - 2022 Nationwide Children’s Hospital, Postdoctoral Fellow

Contact Information

Center for Gene Therapy

Call us at: (614) 355-6778

Email Afrooz Rashnonejad

                    700 Children's DriveColumbus, OH 43205 (map)

Connect with Afrooz Rashnonejad

Connect on LinkedIn

Contact Information

Call us at: (614) 355-6778

Email Afrooz Rashnonejad, MSc, PhD

Center for Gene Therapy700 Children’s DriveColumbus, OH 43205 (map)

Learn more about Afrooz Rashnonejad

Contact Information

  • Call us at:
  • (614) 355-6778
  • Email Afrooz Rashnonejad, MSc, PhD
  • Center for Gene Therapy700 Children’s DriveColumbus, OH 43205 (map)

Learn more about Afrooz Rashnonejad

Research

Lab(s)

Center for Gene Therapy

The Rashnonejad Lab’s research focuses on the development of Adeno-Associated Virus (AAV)-based gene therapies for neurodegenerative and neuromuscular disorders using cutting-edge technologies such as RNAi and CRISPR. Rashnonejad lab is improving PNS targeting by engineering AAV vectors toward developing gene therapies for peripheral neuropathies including Charcot-Marie-Tooth disease (CMT1B and Dejerine–Sottas syndrome (DSS)). Rashnonejad lab is also interested to develop in-utero gene therapies for severe neuromuscular disorders.

Research

Lab(s)

Center for Gene Therapy

The Rashnonejad Lab’s research focuses on the development of Adeno-Associated Virus (AAV)-based gene therapies for neurodegenerative and neuromuscular disorders using cutting-edge technologies such as RNAi and CRISPR. Rashnonejad lab is improving PNS targeting by engineering AAV vectors toward developing gene therapies for peripheral neuropathies including Charcot-Marie-Tooth disease (CMT1B and Dejerine–Sottas syndrome (DSS)). Rashnonejad lab is also interested to develop in-utero gene therapies for severe neuromuscular disorders.

Research

Lab(s)

Center for Gene Therapy

The Rashnonejad Lab’s research focuses on the development of Adeno-Associated Virus (AAV)-based gene therapies for neurodegenerative and neuromuscular disorders using cutting-edge technologies such as RNAi and CRISPR. Rashnonejad lab is improving PNS targeting by engineering AAV vectors toward developing gene therapies for peripheral neuropathies including Charcot-Marie-Tooth disease (CMT1B and Dejerine–Sottas syndrome (DSS)). Rashnonejad lab is also interested to develop in-utero gene therapies for severe neuromuscular disorders.

Lab(s)

Center for Gene Therapy

The Rashnonejad Lab’s research focuses on the development of Adeno-Associated Virus (AAV)-based gene therapies for neurodegenerative and neuromuscular disorders using cutting-edge technologies such as RNAi and CRISPR. Rashnonejad lab is improving PNS targeting by engineering AAV vectors toward developing gene therapies for peripheral neuropathies including Charcot-Marie-Tooth disease (CMT1B and Dejerine–Sottas syndrome (DSS)). Rashnonejad lab is also interested to develop in-utero gene therapies for severe neuromuscular disorders.

Lab(s)

Center for Gene Therapy

The Rashnonejad Lab’s research focuses on the development of Adeno-Associated Virus (AAV)-based gene therapies for neurodegenerative and neuromuscular disorders using cutting-edge technologies such as RNAi and CRISPR. Rashnonejad lab is improving PNS targeting by engineering AAV vectors toward developing gene therapies for peripheral neuropathies including Charcot-Marie-Tooth disease (CMT1B and Dejerine–Sottas syndrome (DSS)). Rashnonejad lab is also interested to develop in-utero gene therapies for severe neuromuscular disorders.

Lab(s)

Center for Gene Therapy

  • Center for Gene Therapy

Biography

Afrooz Rashnonejad, MSc, PhD, is an assistant professor in the Department of Pediatrics at the Ohio State University College of Medicine and principal investigator in the Center for Gene Therapy at the Abigail Wexner Research Institute at Nationwide Children’s Hospital. Dr. Rashnonejad is the chair of the American Society of Gene and Cell therapy (ASGCT)’s New Investigator Committee and she was twice awarded the “Excellence in Research Award” at the ASGCT annual meetings. Dr. Rashnonejad earned her PhD in Biotechnology from Ege University, Turkey, in 2017, after completing two Master’s of Science degrees in Microbiology, and Stem Cell. During her PhD, she developed an in-utero (AKA prenatal or fetal) gene therapy for Spinal Muscular Atrophy (SMA). During this period, she also worked in Dr. Guangping Gao (her PhD co-advisor)’s lab in the Center for Gene Therapy at the University of Massachusetts Medical School as a visiting scientist to master large-scale recombinant AAV production. She then completed postdoctoral training in the lab of Scott Harper, PhD, at the Center for Gene Therapy at Nationwide Children’s Hospital. During her postdoc, Dr. Rashnonejad developed RNA targeting AAV.CRISPR-Cas13 and U7-snRNA mediated exon skipping to treat autosomal dominant inherited Facioscapulohumeral Muscular Dystrophy (FSHD).

Biography

Afrooz Rashnonejad, MSc, PhD, is an assistant professor in the Department of Pediatrics at the Ohio State University College of Medicine and principal investigator in the Center for Gene Therapy at the Abigail Wexner Research Institute at Nationwide Children’s Hospital. Dr. Rashnonejad is the chair of the American Society of Gene and Cell therapy (ASGCT)’s New Investigator Committee and she was twice awarded the “Excellence in Research Award” at the ASGCT annual meetings. Dr. Rashnonejad earned her PhD in Biotechnology from Ege University, Turkey, in 2017, after completing two Master’s of Science degrees in Microbiology, and Stem Cell. During her PhD, she developed an in-utero (AKA prenatal or fetal) gene therapy for Spinal Muscular Atrophy (SMA). During this period, she also worked in Dr. Guangping Gao (her PhD co-advisor)’s lab in the Center for Gene Therapy at the University of Massachusetts Medical School as a visiting scientist to master large-scale recombinant AAV production. She then completed postdoctoral training in the lab of Scott Harper, PhD, at the Center for Gene Therapy at Nationwide Children’s Hospital. During her postdoc, Dr. Rashnonejad developed RNA targeting AAV.CRISPR-Cas13 and U7-snRNA mediated exon skipping to treat autosomal dominant inherited Facioscapulohumeral Muscular Dystrophy (FSHD).

Biography

Afrooz Rashnonejad, MSc, PhD, is an assistant professor in the Department of Pediatrics at the Ohio State University College of Medicine and principal investigator in the Center for Gene Therapy at the Abigail Wexner Research Institute at Nationwide Children’s Hospital. Dr. Rashnonejad is the chair of the American Society of Gene and Cell therapy (ASGCT)’s New Investigator Committee and she was twice awarded the “Excellence in Research Award” at the ASGCT annual meetings. Dr. Rashnonejad earned her PhD in Biotechnology from Ege University, Turkey, in 2017, after completing two Master’s of Science degrees in Microbiology, and Stem Cell. During her PhD, she developed an in-utero (AKA prenatal or fetal) gene therapy for Spinal Muscular Atrophy (SMA). During this period, she also worked in Dr. Guangping Gao (her PhD co-advisor)’s lab in the Center for Gene Therapy at the University of Massachusetts Medical School as a visiting scientist to master large-scale recombinant AAV production. She then completed postdoctoral training in the lab of Scott Harper, PhD, at the Center for Gene Therapy at Nationwide Children’s Hospital. During her postdoc, Dr. Rashnonejad developed RNA targeting AAV.CRISPR-Cas13 and U7-snRNA mediated exon skipping to treat autosomal dominant inherited Facioscapulohumeral Muscular Dystrophy (FSHD).

Afrooz Rashnonejad, MSc, PhD, is an assistant professor in the Department of Pediatrics at the Ohio State University College of Medicine and principal investigator in the Center for Gene Therapy at the Abigail Wexner Research Institute at Nationwide Children’s Hospital. Dr. Rashnonejad is the chair of the American Society of Gene and Cell therapy (ASGCT)’s New Investigator Committee and she was twice awarded the “Excellence in Research Award” at the ASGCT annual meetings. Dr. Rashnonejad earned her PhD in Biotechnology from Ege University, Turkey, in 2017, after completing two Master’s of Science degrees in Microbiology, and Stem Cell. During her PhD, she developed an in-utero (AKA prenatal or fetal) gene therapy for Spinal Muscular Atrophy (SMA). During this period, she also worked in Dr. Guangping Gao (her PhD co-advisor)’s lab in the Center for Gene Therapy at the University of Massachusetts Medical School as a visiting scientist to master large-scale recombinant AAV production. She then completed postdoctoral training in the lab of Scott Harper, PhD, at the Center for Gene Therapy at Nationwide Children’s Hospital. During her postdoc, Dr. Rashnonejad developed RNA targeting AAV.CRISPR-Cas13 and U7-snRNA mediated exon skipping to treat autosomal dominant inherited Facioscapulohumeral Muscular Dystrophy (FSHD).

Afrooz Rashnonejad, MSc, PhD, is an assistant professor in the Department of Pediatrics at the Ohio State University College of Medicine and principal investigator in the Center for Gene Therapy at the Abigail Wexner Research Institute at Nationwide Children’s Hospital. Dr. Rashnonejad is the chair of the American Society of Gene and Cell therapy (ASGCT)’s New Investigator Committee and she was twice awarded the “Excellence in Research Award” at the ASGCT annual meetings.

Dr. Rashnonejad earned her PhD in Biotechnology from Ege University, Turkey, in 2017, after completing two Master’s of Science degrees in Microbiology, and Stem Cell. During her PhD, she developed an in-utero (AKA prenatal or fetal) gene therapy for Spinal Muscular Atrophy (SMA). During this period, she also worked in Dr. Guangping Gao (her PhD co-advisor)’s lab in the Center for Gene Therapy at the University of Massachusetts Medical School as a visiting scientist to master large-scale recombinant AAV production. She then completed postdoctoral training in the lab of Scott Harper, PhD, at the Center for Gene Therapy at Nationwide Children’s Hospital. During her postdoc, Dr. Rashnonejad developed RNA targeting AAV.CRISPR-Cas13 and U7-snRNA mediated exon skipping to treat autosomal dominant inherited Facioscapulohumeral Muscular Dystrophy (FSHD).

Academic and Clinical Areas

Center for Gene Therapy

Principal Investigator

Primary Department

Center for Gene Therapy

Academic and Clinical Areas

Center for Gene Therapy

Principal Investigator

Primary Department

Center for Gene Therapy

Academic and Clinical Areas

Center for Gene Therapy

Principal Investigator

Primary Department

Center for Gene Therapy

Center for Gene Therapy

Principal Investigator

Primary Department

Center for Gene Therapy

  • Center for Gene Therapy
  • Principal Investigator
  • Primary Department
  • Center for Gene Therapy

Awards, Honors & Organizations

Excellence in Research Award, 23rd ASGCT Annual Meeting, USA, 2020 President’s Prize, 24th World Muscle Society (WMS), Copenhagen, Denmark, 2019 Excellence in Research Award, 22nd ASGCT Annual Meeting, Washington DC, USA, 2019 Best Project Award, National Health Science Project Competition, UPROJECT, Turkey, 2016 PhD Fellowship Award, the Scientific and Technological Research Council of Turkey, (TUBITAK/BIDEB-2215), 2012-2015 Chair, American Society for Gene and Cell Therapy (ASGCT) New Investigator Committee, USA, 2021 - Present Member, Peripheral Nerve Society (PNS), 2021 - Present Chair, Research Institute Trainee Association (RITA), Nationwide Children’s Hospital, 2021 - 2022 Member, International Fetal Transplantation and Immunology Society (IFETIS), USA, 2020 - Present Member, World Muscle Society (WMS), 2019 - Present Associate Member, American Society for Gene and Cell Therapy (ASGCT), USA, 2017 - Present Member, American Society for Biochemistry and Molecular Biology, USA, 2017 - Present Member, National Postdoctoral Association, USA, 2017 - 2022

Awards, Honors & Organizations

Excellence in Research Award, 23rd ASGCT Annual Meeting, USA, 2020 President’s Prize, 24th World Muscle Society (WMS), Copenhagen, Denmark, 2019 Excellence in Research Award, 22nd ASGCT Annual Meeting, Washington DC, USA, 2019 Best Project Award, National Health Science Project Competition, UPROJECT, Turkey, 2016 PhD Fellowship Award, the Scientific and Technological Research Council of Turkey, (TUBITAK/BIDEB-2215), 2012-2015 Chair, American Society for Gene and Cell Therapy (ASGCT) New Investigator Committee, USA, 2021 - Present Member, Peripheral Nerve Society (PNS), 2021 - Present Chair, Research Institute Trainee Association (RITA), Nationwide Children’s Hospital, 2021 - 2022 Member, International Fetal Transplantation and Immunology Society (IFETIS), USA, 2020 - Present Member, World Muscle Society (WMS), 2019 - Present Associate Member, American Society for Gene and Cell Therapy (ASGCT), USA, 2017 - Present Member, American Society for Biochemistry and Molecular Biology, USA, 2017 - Present Member, National Postdoctoral Association, USA, 2017 - 2022

Awards, Honors & Organizations

Excellence in Research Award, 23rd ASGCT Annual Meeting, USA, 2020 President’s Prize, 24th World Muscle Society (WMS), Copenhagen, Denmark, 2019 Excellence in Research Award, 22nd ASGCT Annual Meeting, Washington DC, USA, 2019 Best Project Award, National Health Science Project Competition, UPROJECT, Turkey, 2016 PhD Fellowship Award, the Scientific and Technological Research Council of Turkey, (TUBITAK/BIDEB-2215), 2012-2015 Chair, American Society for Gene and Cell Therapy (ASGCT) New Investigator Committee, USA, 2021 - Present Member, Peripheral Nerve Society (PNS), 2021 - Present Chair, Research Institute Trainee Association (RITA), Nationwide Children’s Hospital, 2021 - 2022 Member, International Fetal Transplantation and Immunology Society (IFETIS), USA, 2020 - Present Member, World Muscle Society (WMS), 2019 - Present Associate Member, American Society for Gene and Cell Therapy (ASGCT), USA, 2017 - Present Member, American Society for Biochemistry and Molecular Biology, USA, 2017 - Present Member, National Postdoctoral Association, USA, 2017 - 2022

Excellence in Research Award, 23rd ASGCT Annual Meeting, USA, 2020 President’s Prize, 24th World Muscle Society (WMS), Copenhagen, Denmark, 2019 Excellence in Research Award, 22nd ASGCT Annual Meeting, Washington DC, USA, 2019 Best Project Award, National Health Science Project Competition, UPROJECT, Turkey, 2016 PhD Fellowship Award, the Scientific and Technological Research Council of Turkey, (TUBITAK/BIDEB-2215), 2012-2015 Chair, American Society for Gene and Cell Therapy (ASGCT) New Investigator Committee, USA, 2021 - Present Member, Peripheral Nerve Society (PNS), 2021 - Present Chair, Research Institute Trainee Association (RITA), Nationwide Children’s Hospital, 2021 - 2022 Member, International Fetal Transplantation and Immunology Society (IFETIS), USA, 2020 - Present Member, World Muscle Society (WMS), 2019 - Present Associate Member, American Society for Gene and Cell Therapy (ASGCT), USA, 2017 - Present Member, American Society for Biochemistry and Molecular Biology, USA, 2017 - Present Member, National Postdoctoral Association, USA, 2017 - 2022

  • Excellence in Research Award, 23rd ASGCT Annual Meeting, USA, 2020
  • President’s Prize, 24th World Muscle Society (WMS), Copenhagen, Denmark, 2019
  • Excellence in Research Award, 22nd ASGCT Annual Meeting, Washington DC, USA, 2019
  • Best Project Award, National Health Science Project Competition, UPROJECT, Turkey, 2016
  • PhD Fellowship Award, the Scientific and Technological Research Council of Turkey, (TUBITAK/BIDEB-2215), 2012-2015
  • Chair, American Society for Gene and Cell Therapy (ASGCT) New Investigator Committee, USA, 2021 - Present
  • Member, Peripheral Nerve Society (PNS), 2021 - Present
  • Chair, Research Institute Trainee Association (RITA), Nationwide Children’s Hospital, 2021 - 2022
  • Member, International Fetal Transplantation and Immunology Society (IFETIS), USA, 2020 - Present
  • Member, World Muscle Society (WMS), 2019 - Present
  • Associate Member, American Society for Gene and Cell Therapy (ASGCT), USA, 2017 - Present
  • Member, American Society for Biochemistry and Molecular Biology, USA, 2017 - Present
  • Member, National Postdoctoral Association, USA, 2017 - 2022

Education

Postdoctoral Training

Nationwide Children’s Hospital

Date Completed: 03/31/2022

Graduate School

Ege University

Date Completed: 04/30/2017

Education

Postdoctoral Training

Nationwide Children’s Hospital

Date Completed: 03/31/2022

Graduate School

Ege University

Date Completed: 04/30/2017

Education

Postdoctoral Training

Nationwide Children’s Hospital

Date Completed: 03/31/2022

Graduate School

Ege University

Date Completed: 04/30/2017

Postdoctoral Training

Nationwide Children’s Hospital

Date Completed: 03/31/2022

Graduate School

Ege University

Date Completed: 04/30/2017

Postdoctoral Training

Nationwide Children’s Hospital

Date Completed: 03/31/2022

Graduate School

Ege University

Date Completed: 04/30/2017

Professional Experience

2022 - Present Nationwide Children’s Hospital, Principal Investigator2022 - Present The Ohio State University, Assistant Professor2017 - 2022 Nationwide Children’s Hospital, Postdoctoral Fellow

Professional Experience

2022 - Present Nationwide Children’s Hospital, Principal Investigator2022 - Present The Ohio State University, Assistant Professor2017 - 2022 Nationwide Children’s Hospital, Postdoctoral Fellow

Professional Experience

2022 - Present Nationwide Children’s Hospital, Principal Investigator2022 - Present The Ohio State University, Assistant Professor2017 - 2022 Nationwide Children’s Hospital, Postdoctoral Fellow

2022 - Present Nationwide Children’s Hospital, Principal Investigator2022 - Present The Ohio State University, Assistant Professor2017 - 2022 Nationwide Children’s Hospital, Postdoctoral Fellow

2022 - Present Nationwide Children’s Hospital, Principal Investigator

Contact Information

Center for Gene Therapy

Call us at: (614) 355-6778

Email Afrooz Rashnonejad

                    700 Children's DriveColumbus, OH 43205 (map)

Contact Information

Center for Gene Therapy

Call us at: (614) 355-6778

Email Afrooz Rashnonejad

                    700 Children's DriveColumbus, OH 43205 (map)

Contact Information

Center for Gene Therapy

Call us at: (614) 355-6778

Email Afrooz Rashnonejad

                    700 Children's DriveColumbus, OH 43205 (map)

Center for Gene Therapy

Call us at: (614) 355-6778

Email Afrooz Rashnonejad

                    700 Children's DriveColumbus, OH 43205 (map)

Call us at: (614) 355-6778

Email Afrooz Rashnonejad

                    700 Children's DriveColumbus, OH 43205 (map)

Call us at: (614) 355-6778

Email Afrooz Rashnonejad

                    700 Children's DriveColumbus, OH 43205 (map)
  • Call us at:
  • (614) 355-6778
  • Email Afrooz Rashnonejad
  • 700 Children’s DriveColumbus, OH 43205 (map)

Connect with Afrooz Rashnonejad

Connect on LinkedIn